Dendritic cells as potential targets for mucosal immunotherapy

Current Opinion in Allergy and Clinical Immunology

Volumn 9, Issue 6, 2009, Pages 554-557

  Allam, Jean Pierre ^a   Bieber, Thomas ^a   Novak, Natalija ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Adjuvants; Langerhans cells; Oral mucosa; Specific immunotherapy; Sublingual immunotherapy

Indexed keywords

ALLERGEN; CYTOKINE; INTERLEUKIN 10; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2;

ALLERGIC RHINITIS; ANTIGEN PRESENTING CELL; CD34 SELECTION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; LANGERHANS CELL; MOUTH CAVITY; MOUTH MUCOSA; MUCOSA CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ALLERGENS; ANIMALS; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION ROUTES; HUMANS; IMMUNE TOLERANCE; IMMUNOMODULATION; MOUTH MUCOSA; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; T-LYMPHOCYTES, REGULATORY;

EID: 70350774139     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32833239a9     Document Type: Review

References (33)

1. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60:4-12.
2. Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006; 97:141-148.
3. Milgrom H, Tran ZV. Sublingual immunotherapy, meta-analysis, and knowledge in the age of information. J Allergy Clin Immunol 2009; 124:162-163.
4. Compalati E, Penagos M, Tarantini F, et al. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol 2009; 102:22-28.
5. Scadding G, Durham S. Mechanisms of sublingual immunotherapy. J Asthma 2009; 46:322-334.
6. Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 2009; 123:735-746; quiz 747.
7. Novak N, Haberstok J, Geiger E, Bieber T. Dendritic cells in allergy. Allergy 1999; 54:792-803.
8. Novak N, Haberstok J, Bieber T, Allam JP. The immune privilege of the oral mucosa. Trends Mol Med 2008; 14:191-198.
9. Eslami A, Gallant-Behm CL, Hart DA, et al. Expression of integrin alphavbeta6 and tgf-beta in scarless vs scar-forming wound healing. J Histochem Cytochem 2009; 57:543-557.
10. Marcucci F, Incorvaia C, Sensi L, et al. Lack of inflammatory cells in the oral mucosa of subjects undergoing sublingual immunotherapy. Int J Immunopathol Pharmacol 2008; 21:609-614.
11. Bagnasco M, Altrinetti V, Pesce G, et al. Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers. Int Arch Allergy Immunol 2005; 138:197-202.
12. Bagnasco M, Passalacqua G, Villa G, et al. Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers. Clin Exp Allergy 2001; 31:54-60.
13. Marcucci F, Incorvaia C, Sensi L, et al. Lack of inflammatory cells in the oral mucosa of subjects undergoing sublingual immunotherapy. Int Arch Allergy Immunol 2005; 138:197-202.
14. Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 2007; 25:381-418.
15. Steinman RM. Dendritic cells: understanding immunogenicity. Eur J Immunol 2007; 37 (Suppl 1):S53-S60.
16. Novak N, Allam JP, Betten H, et al. The role of antigen presenting cells at distinct anatomic sites: they accelerate and they slow down allergies. Allergy 2004; 59:5-14.
17. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002; 23:445-449.
18. Mascarell L, Lombardi V, Louise A, et al. Oral dendritic cells mediate antigenspecific tolerance by stimulating Th1 and regulatory CD4p T cells. J Allergy Clin Immunol 2008; 122:603.e605-609.e605.
19. Song JH, Kim JI, Kwon HJ, et al. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination. J Immunol 2009; 182:6851-6860.
20. Allam JP, Niederhagen B, Bucheler M, et al. Comparative analysis of nasal and oral mucosa dendritic cells. Allergy 2006; 61:166-172.
21. Allam JP, Stojanovski G, Friedrichs N, et al. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy 2008; 63:720-727.
22. Allam JP, Novak N, Fuchs C, et al. Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression. J Allergy Clin Immunol 2003; 112:141-148.
23. Allam JP, Klein E, Bieber T, Novak N. Transforming growth factor-beta1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro. J Invest Dermatol 2004; 123:676-682.
24. Wright SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431-1433.
25. Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 2005; 3:36-46.
26. Rakoff-Nahoum S, Hao L, Medzhitov R. Role of Toll-like receptors in spontaneous commensal-dependent colitis. Immunity 2006; 25:319-329.
27. Allam JP, Peng WM, Appel T, et al. Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J Allergy Clin Immunol 2008; 121:368.e361-374.e361.
28. Lombardi V, Van Overtvelt L, Horiot S, et al. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route. Clin Exp Allergy 2008; 38:1819-1829.
29. Mascarell L, Van Overtvelt L, Lombardi V, et al. A synthetic triacylated pseudodipeptide molecule promotes Th1/Treg immune responses and enhances tolerance induction via the sublingual route. Vaccine 2007; 26:108-118.
30. Van Overtvelt L, Lombardi V, Razafindratsita A, et al. IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol 2008; 145:152-162.
31. Saint-Lu N, Tourdot S, Razafindratsita A, et al. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction. Allergy 2009; 64:1003-1013.
32. Razafindratsita A, Saint-Lu N, Mascarell L, et al. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J Allergy Clin Immunol 2007; 120:278-285.
33. Panzner P, Petras M, Sykora T, Lesna I. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually. Respir Med 2008; 102:1296-1304.